Abstract
Full text links
Read article at publisher's site: https://doi.org/10.1007/bf01556147
Read article for free, from open access legal sources, via Unpaywall: https://link.springer.com/content/pdf/10.1007%2FBF01556147.pdf
References
Articles referenced by this article (13)
Brès, P.: Données récentes apportées par les enquêtes sérologiques sur la prévalence des arbovirus en Afrique, avec référence spéciale à la fièvre jaune. Bull. Wld Hlth Org.43, 223–267 (1970).
Casals, J.: Antigenic classification of arthropod-borne viruses. Proc. 6th Int. Congr. trop. Med. Malar.5, 34–47 (1959).
Casals, J.: Procedures for identification of arthropod-borne viruses. Bull. Wld Hlth Org.24, 723–734 (1961).
Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses.
Am J Trop Med Hyg, (5):561-573 1958
MED: 13571577
Comité d'experts de la fièvre jaune. Org. mond. Santé. Sér. Rapp. techn.479, Genève, 1971.
Filipe, A. R., R. G.Carvalho, A.Relvas, and V. M.Casaca: to be published.
Hammon, W. McD., andT. H. Work: Arbovirus infection in man. In: Diagnostic Procedures for Viral and Rickettsial Diseases, 3rd Ed. pp. 268–311. New York: Amer. Publ. Hlth Ass., 1964.
Kärber, G.: Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Naunyn-Schmiedberg's Arch. exp. Path. Pharmak.162, 480–483 (1931).
Clinical and serologic response of man to immunization with attenuated dengue and yellow fever viruses.
J Immunol, (5):352-364 1956
MED: 13385504
Sérié, C., J. Casals, R. Panthier, P. Brès etM. C. Williams: Études sur la fièvre jaune en Ethiopie. 2. Enquête sérologique sur la population humaine. Bull. Wld Hlth Org.38, 843–854 (1968).
Show 3 more references (10 of 13)
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1007/bf01556147
Article citations
Nucleic Acid Vaccine Platform for DENGUE and ZIKA Flaviviruses.
Vaccines (Basel), 10(6):834, 24 May 2022
Cited by: 5 articles | PMID: 35746442 | PMCID: PMC9229673
Review Free full text in Europe PMC
Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine.
N Engl J Med, 385(12):e35, 01 Sep 2021
Cited by: 118 articles | PMID: 34525286 | PMCID: PMC6824915
Case Series of Laboratory-Associated Zika Virus Disease, United States, 2016-2019.
Emerg Infect Dis, 27(5):1296-1300, 01 May 2021
Cited by: 2 articles | PMID: 33900178 | PMCID: PMC8084508
Review Free full text in Europe PMC
SARS-CoV-2 vaccination in the context of original antigenic sin.
Hum Vaccin Immunother, 18(1):1949953, 09 Jul 2021
Cited by: 5 articles | PMID: 34242123 | PMCID: PMC8290366
A Glimmer of Hope: Recent Updates and Future Challenges in Zika Vaccine Development.
Viruses, 12(12):E1371, 30 Nov 2020
Cited by: 16 articles | PMID: 33266129 | PMCID: PMC7761420
Review Free full text in Europe PMC
Go to all (57) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
TWO EPISODES OF DENGUE FEVER, CAUSED BY TYPES 4 AND 1 VIRUSES, IN AN INDIVIDUAL PREVIOUSLY IMMUNIZED AGAINST YELLOW FEVER.
Am J Trop Med Hyg, 14:448-450, 01 May 1965
Cited by: 4 articles | PMID: 14292751
Yellow fever vaccine. V. Antibody response in maonkeys inoculated with graded doses of the 17D vaccine.
Appl Microbiol, 23(5):908-913, 01 May 1972
Cited by: 5 articles | PMID: 4624211 | PMCID: PMC380469
Yellow fever vaccine: direct challenge of monkeys given graded doses of 17D vaccine.
Appl Microbiol, 25(4):539-544, 01 Apr 1973
Cited by: 89 articles | PMID: 4633476 | PMCID: PMC380857
Current status, challenges and perspectives in the development of vaccines against yellow fever, dengue, Zika and chikungunya viruses.
Acta Trop, 182:257-263, 15 Mar 2018
Cited by: 27 articles | PMID: 29551394
Review